CD48 as a novel molecular target for antibody therapy in multiple myeloma.
Hosen N, Ichihara H, Mugitani A, Aoyama Y, Fukuda Y, Kishida S, Matsuoka Y, Nakajima H, Kawakami M, Yamagami T, Fuji S, Tamaki H, Nakao T, Nishida S, Tsuboi A, Iida S, Hino M, Oka Y, Oji Y, Sugiyama H.
Hosen N, et al.
Br J Haematol. 2012 Jan;156(2):213-24. doi: 10.1111/j.1365-2141.2011.08941.x. Epub 2011 Nov 21.
Br J Haematol. 2012.
PMID: 22098460
Free article.